Pemetrexed Phase 2

DRUG2 trials

Sponsors

Eli Lilly and Company, Saint John's Cancer Institute

Conditions

ChordomaChordomasNon-Small Cell Lung Cancer

Phase 1

Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer

CompletedNCT00529100

Eli Lilly and CompanyNon-Small Cell Lung Cancer

Start: 2005-12-31End: 2012-09-30Updated: 2013-07-09

Phase 2

Pembrolizumab and Pemetrexed for Progressive Chordoma

RecruitingNCT06794645

Saint John's Cancer InstituteChordoma, Chordomas

Start: 2025-01-31End: 2026-11-30Target: 21Updated: 2025-01-27